PURPOSE: We explored whether AMH, as a surrogate for oocyte supply, varies by FMR1 genotype in women diagnosed with diminished ovarian reserve (DOR), a subset of the Primary Ovarian Insufficiency phenotype. Research is inconsistent on the relationship between AMH and FMR1 repeat length, controlling for age. METHOD: Seventy-nine cycling women diagnosed with DOR, and without a family history of fragile X syndrome, provided blood for FMR1 and AMH testing. DOR was defined as elevated FSH and/or low AMH and/or low antral follicle count, with regular menses. FMR1 CGG repeats were stratified by the larger allele <35 repeats (n = 70) v. ≥35 repeats (n = 9). Quadratic and linear models were fit to predict log (AMH) controlling for age. The AMH sample used as the outcome variable was drawn at a later date than the diagnostic AMH. RESULTS: Serum AMH concentration median was 0.30 ng/mL; Ages ranged from 26-43 years. A quadratic model (including age(2)) did not show a relationship with FMR1 CGG level (p-value = 0.25). A linear model of log (AMH), corresponding to an exponential decline of AMH with increasing age, was significantly different, and had a steeper slope, for women with ≥ 35 CGG repeats than women with < 35 repeats (p = 0.035). CONCLUSION: Findings suggest a greater rate of follicular loss that starts at later ages in women with DOR and ≥ 35 CGG repeats.
PURPOSE: We explored whether AMH, as a surrogate for oocyte supply, varies by FMR1 genotype in women diagnosed with diminished ovarian reserve (DOR), a subset of the Primary Ovarian Insufficiency phenotype. Research is inconsistent on the relationship between AMH and FMR1 repeat length, controlling for age. METHOD: Seventy-nine cycling women diagnosed with DOR, and without a family history of fragile X syndrome, provided blood for FMR1 and AMH testing. DOR was defined as elevated FSH and/or low AMH and/or low antral follicle count, with regular menses. FMR1 CGG repeats were stratified by the larger allele <35 repeats (n = 70) v. ≥35 repeats (n = 9). Quadratic and linear models were fit to predict log (AMH) controlling for age. The AMH sample used as the outcome variable was drawn at a later date than the diagnostic AMH. RESULTS: Serum AMH concentration median was 0.30 ng/mL; Ages ranged from 26-43 years. A quadratic model (including age(2)) did not show a relationship with FMR1 CGG level (p-value = 0.25). A linear model of log (AMH), corresponding to an exponential decline of AMH with increasing age, was significantly different, and had a steeper slope, for women with ≥ 35 CGG repeats than women with < 35 repeats (p = 0.035). CONCLUSION: Findings suggest a greater rate of follicular loss that starts at later ages in women with DOR and ≥ 35 CGG repeats.
Authors: Benjamin Leader; Aparna Hegde; Quentin Baca; Kimberly Stone; Benjamin Lannon; David B Seifer; Frank Broekmans; Valerie L Baker Journal: Fertil Steril Date: 2012-07-06 Impact factor: 7.329
Authors: S L Broer; M J C Eijkemans; G J Scheffer; I A J van Rooij; A de Vet; A P N Themmen; J S E Laven; F H de Jong; E R Te Velde; B C Fauser; F J M Broekmans Journal: J Clin Endocrinol Metab Date: 2011-05-25 Impact factor: 5.958
Authors: C B Karimov; V A Moragianni; A Cronister; S Srouji; J Petrozza; C Racowsky; E Ginsburg; K L Thornton; C K Welt Journal: Hum Reprod Date: 2011-06-06 Impact factor: 6.918
Authors: Lisa M Pastore; Steven L Young; Valerie L Baker; Logan B Karns; Christopher D Williams; Lawrence M Silverman Journal: Reprod Sci Date: 2012-05-10 Impact factor: 3.060
Authors: Sonya M Schuh-Huerta; Nicholas A Johnson; Mitchell P Rosen; Barbara Sternfeld; Marcelle I Cedars; Renee A Reijo Pera Journal: Hum Reprod Date: 2011-11-24 Impact factor: 6.918
Authors: Bat-Sheva L Maslow; Stephanie Davis; Lawrence Engmann; John C Nulsen; Claudio A Benadiva Journal: J Assist Reprod Genet Date: 2016-05-17 Impact factor: 3.412
Authors: Lisa M Pastore; Mindy S Christianson; James Stelling; William G Kearns; James H Segars Journal: J Assist Reprod Genet Date: 2017-10-02 Impact factor: 3.412